Scotts Miracle-gro CO

Market Movers (8-K)

NYSE
Scotts Miracle-Gro reported third-quarter results, exceeding expectations and raising its full-year non-GAAP adjusted EPS guidance to $4.30-$4.45.
Better than expected
NYSE
The Scotts Miracle-Gro Company announces a leadership transition with Nate Baxter appointed President & CEO, succeeding long-time leader Jim Hagedorn.
NYSE
Scotts Miracle-Gro announced robust second quarter results with a 5% increase in net sales and significant gross margin improvement, driving EPS growth and reducing net leverage.
Better than expected
NYSE
The Scotts Miracle-Gro Company has completed the sale of its Hawthorne subsidiary to Vireo Growth, Inc. for Vireo shares and warrants, reaffirming its fiscal 2026 guidance.
NYSE
Scotts Miracle-Gro shareholders approved an increase of 2.75 million shares for its long-term incentive plan and re-elected four directors at its annual meeting.
Capital raise
NYSE
Scotts Miracle-Gro reported first-quarter results, announced the divestiture of its Hawthorne subsidiary, and unveiled a new $500 million share repurchase program.

Quarterly Earnings (10-Q)

NYSE
Scotts Miracle-Gro reported a wider net loss in its first fiscal quarter, primarily driven by a significant non-cash charge related to the reclassification of its Hawthorne business as a discontinued operation, despite improved performance in continuing operations.
Worse than expected
NYSE
Scotts Miracle-Gro reported a significant increase in net income and diluted EPS for the third quarter and first nine months of fiscal 2025, driven by improved gross margins and reduced interest expense, despite a slight decline in net sales.
Capital raise
Better than expected
NYSE
Scotts Miracle-Gro's Q2 2025 net income increased significantly year-over-year, driven by improved gross margins and reduced restructuring charges, despite a decrease in net sales.
Better than expected
Capital raise
NYSE
Scotts Miracle-Gro's first quarter of fiscal year 2025 shows a reduced net loss compared to the previous year, driven by increased sales in the U.S. Consumer segment but offset by challenges in the Hawthorne division.
Better than expected
Capital raise
NYSE
Scotts Miracle-Gro's third-quarter results show a significant increase in net income, driven by strong sales in the U.S. consumer segment and improved gross margins.
Better than expected
Capital raise
NYSE
Scotts Miracle-Gro's second-quarter results show improved earnings driven by restructuring and cost management, despite a slight dip in net sales.
Better than expected
Capital raise

Annual Reports (10-K)

NYSE
The Scotts Miracle-Gro Company reported a significant turnaround in fiscal 2025, achieving net income of $145.2 million and improved gross margin, despite a slight decrease in overall net sales.
Capital raise
Better than expected
NYSE
Scotts Miracle-Gro has announced executive team changes, including the appointment of a new president and COO, a chief of staff, and a transition plan for the CFO, while reaffirming its fiscal 2025 guidance.

Insider Trading (Form 4)

NYSE
Stephen L Johnson, a Director of Scotts Miracle-Gro Co, sold 1,171 shares of common stock on July 30, 2026 for $68.32 per share.
NYSE
Mark J Scheiwer, EVP, CFO & CAO of Scotts Miracle-Gro Co, received 4 shares of common stock on July 27, 2026.
NYSE
Director Stephen L. Johnson of The Scotts Miracle-Gro Company acquired 105 common shares through a deferred stock unit conversion.
NYSE
Mark J. Scheiwer, EVP, CFO & CAO of Scotts Miracle-Gro Co, acquired company shares through a 10b5-1 plan.
NYSE
Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, reported a transaction involving the sale of common shares.
NYSE
Nick Miaritis, EVP & Chief Brand Officer at Scotts Miracle-Gro, reported a transaction involving common shares.

Proxy Statements (Def-14A)

NYSE
Scotts Miracle-Gro announces its 2026 Annual Meeting of Shareholders, detailing proposals including director elections, executive compensation, auditor ratification, and an amendment to its Long-Term Incentive Plan.
NYSE
The Scotts Miracle-Gro Company will hold its 2026 Annual Meeting to elect directors, vote on executive compensation, ratify auditors, and approve an increase in shares for its Long-Term Incentive Plan.
Better than expected
NYSE
Scotts Miracle-Gro's annual shareholder meeting will be held virtually on January 27, 2025, with proxy voting open until January 26, 2025.
NYSE
Scotts Miracle-Gro will hold its 2025 Annual Meeting of Shareholders virtually on January 27, 2025, to vote on director elections, executive compensation, auditor ratification, and an amendment to the Discounted Stock Purchase Plan.

Schedule 13D - Activist Investments

NYSE
Hagedorn Partnership, L.P. and its affiliates updated their beneficial ownership in The Scotts Miracle-Gro Company, disclosing a new $75 million revolving credit facility and a 10b5-1 trading plan for future share sales.
Capital raise
NYSE
Hagedorn Partnership and its General Partners filed an amended Schedule 13D, detailing their collective 23.1% beneficial ownership in The Scotts Miracle-Gro Company and recent insider transactions.

Schedule 13G - Passive Investments

NYSE
The Vanguard Group has filed an amendment to its Schedule 13G, reporting 0% beneficial ownership in Scotts Miracle-Gro Co/The following an internal realignment.
NYSE
Investment adviser EARNEST Partners LLC has reported a 6.5% beneficial ownership stake in Scotts Miracle-Gro Co., holding 3,756,898 common shares as of June 30, 2025.
NYSE
Investment adviser Kayne Anderson Rudnick Investment Management, LLC has filed an amended Schedule 13G, disclosing a 3.15% beneficial ownership stake in Scotts Miracle-Gro Co as of March 31, 2025.